NCT06440161

Brief Summary

Background To determine whether venous congestion is an important predictor of postoperative kidney injury and other adverse events after type A aortic dissection (TAAD). Methods Authors collected data of adults who underwent surgery for TAAD between January 2016 and July 2023. Primary exposures were venous congestion defined by central venous pressure (CVP) and mean arterial pressure (MAP). The primary outcomes were acute kidney injury (AKI) and acute injury disease (AKD). The secondary outcomes encompassed death and stroke. Restricted cubic spline regression model was used to adjust for confounding factors and multiple comparisons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
543

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 6, 2024

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 3, 2024

Completed
Last Updated

June 3, 2024

Status Verified

September 1, 2023

Enrollment Period

3 months

First QC Date

May 6, 2024

Last Update Submit

May 28, 2024

Conditions

Keywords

Acute Kidney InjuryIntraoperative HypotensionVenous CongestionAcute Kidney DiseaseType A Aortic Dissection

Outcome Measures

Primary Outcomes (2)

  • The Incidence of AKI

    AKI diagnosis adhered to the Kidney Disease Improvement Global Prognosis Organization (KDIGO) criteria.

    After the surgery,up to 7 days

  • The Incidence of AKD

    AKD staging was determined based on the Acute Disease Quality Initiative (ADQI) Working Group consensus, using available Scr values from 8 to 90 days post-surgery.

    After the surgery,longer than 7 days but within 90 days

Secondary Outcomes (5)

  • The days of stay in hospital

    perioperatively

  • The days of stay in ICU

    after surgery

  • The incidence of in-hospital mortality

    after surgery

  • The incidence of 30-day all-cause mortality

    after surgery

  • The incidence of stroke

    after surgery

Interventions

After the induction of anaesthesia, a central venous or pulmonary artery catheter was positioned. Based on prior studies, thresholds for central venous pressure were set at 10, 12, 16, and 20 mm Hg. Venous congestion was quantified by time exceeding each CVP threshold and the area under the curve (AUC) surpassing each CVP threshold in mmHg × min. Assessments were limited to pre- and post-CPB periods, as the venous drainage cannulate generated negative CVP during CPB. An arterial catheter was installed upon room admission. Continuous arterial blood pressure monitoring commenced after exposure to atmospheric pressure and calibration to zero. The MAP was determined using the formula: 2/3 × diastolic blood pressure + 1/3 × systolic blood pressure. Data were logged by automated software every minute. Established thresholds for MAP were 55, 65, and 75 mm Hg. Hypotension was quantified as (1) time under each MAP threshold in minutes and (2) the AUC below each MAP threshold in mmHg × min.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eligible patients underwent surgery for TAAD.

You may qualify if:

  • \) Eligible patients were adults, aged 18 or older.

You may not qualify if:

  • Lacking preoperative serum creatinine (Scr) values
  • Insufficient hemodynamic or laboratory data
  • Exhibiting a preoperative Scr level ≥133 μmol/L
  • Patients with renal insufficiency before surgery
  • Patients on preoperative dialysis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing First Hospital

Nanjing, Jiangsu, 210000, China

Location

MeSH Terms

Conditions

Acute Kidney InjuryHyperemia

Interventions

COP protocol 2Arterial Pressure

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Blood PressureHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Study Officials

  • Ya-li Ge

    The First Affiliated Hospital with Nanjing Medical University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2024

First Posted

June 3, 2024

Study Start

October 1, 2023

Primary Completion

January 1, 2024

Study Completion

March 1, 2024

Last Updated

June 3, 2024

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations